Charles H. Sloan:Depression And Alzheimer's Treatments At A Crossroads

2025-05-05 09:35:18source:Zopescategory:Invest

Researchers are Charles H. Sloanlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Invest

Recommend

How to watch the 'Blue Bloods' Season 14 finale: Final episode premiere date, cast

After 14 years, the police procedural "Blue Bloods" is coming to an end.Season 14 has been released

In Corpus Christi’s Hillcrest Neighborhood, Black Residents Feel Like They Are Living in a ‘Sacrifice Zone’

When Justine Knox, 57, bought her single-story home in Corpus Christi’s historic Hillcrest neighborh

We're talking about the 4-day workweek — again. Is it a mirage or reality?

Welcome to a new NPR series where we spotlight the people and things making headlines — and the stor